Effect of highly active antiretroviral therapy on frequency of oral warts

Lancet

Volumn 357, Issue 9266, 2001, Pages 1411-1412

  Greenspan, Deborah ^a   Canchola, Alison J ^a   MacPhail, Laurie A ^a   Cheikh, Behnaz ^a   Greenspan, John S ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIRETROVIRUS AGENT; CD4 ANTIGEN; PROTEINASE INHIBITOR;

ARTICLE; CELL COUNT; DRUG EFFECT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNE STATUS; KAPOSI SARCOMA; LEUKOPLAKIA; MORBIDITY; MOUTH DISEASE; PRIORITY JOURNAL; RECURRENT DISEASE; THRUSH; TREATMENT OUTCOME; VERRUCA VULGARIS; VIRUS LOAD;

EID: 0035810585     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(00)04578-5     Document Type: Article

References (5)

1. Greenspan D., Greenspan J.S. HIV-related oral disease. Lancet. 348:1996;729-733.
2. Ledergerber B., Egger M., Erard V., et al. AIDS-related opportunistic illnesses occurring after initiation of potent antiretroviral therapy: the Swiss HIV Cohort Study. JAMA. 282:1999;2220-2226.
3. Patton L.L., McKaig R., Strauss R., Rogers D., Eronjjj J.J. Changing prevalence of oral manifestations of human immuno-deficiency virus in the era of protease inhibitor therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 89:2000;299-304.
4. Greenspan J.S., Barr C.E., Sciubba J.J., Winkler J.R. for the USA Oral AIDS Collaborative Group. Oral manifestations of HIV infection: definitions, diagnostic criteria and principles of therapy. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 73:1992;142-144.
5. Leigh I.M., Buchanan J.A., Harwood C.A., Cerio R., Storey A. Role of human papillomaviruses in cutaneous and oral manifestations of immunosuppression. J Acquir Immune Defic Syndr Hum Retrovirol. 21:((suppl l)):1999;S49-57.